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Abstract 
Background: Increasing numbers of patients with cardiovascular implantable electronic devices (CIEDs) and limited 
follow-up capacities highlight unmet challenges in clinical electrophysiology. Integrated software  (MediConnect®) 
enabling fully digital processing of device interrogation data has been commercially developed to facilitate follow-up 
visits. We sought to assess feasibility of fully digital data processing (FDDP) during ambulatory device follow-up in a 
high-volume tertiary hospital to provide guidance for future users of FDDP software.
Methods: A total of 391 patients (mean age, 70 years) presenting to the outpatient department for routine device 
follow-up were analyzed (pacemaker, 44%; implantable cardioverter defibrillator, 39%; cardiac resynchronization 
therapy device, 16%).
Results: Quality of data transfer and follow-up duration were compared between digital (n = 265) and manual pro-
cessing of device data (n = 126). Digital data import was successful, complete and correct in 82% of cases when early 
software versions were used. When using the most recent software version the rate of successful digital data import 
increased to 100%. Software-based import of interrogation data was complete and without failure in 97% of cases. 
The mean duration of a follow-up visit did not differ between the two groups (digital 18.7 min vs. manual data transfer 
18.2 min).
Conclusions: FDDP software was successfully implemented into the ambulatory follow-up of patients with 
implanted pacemakers and defibrillators. Digital data import into electronic patient management software was 
feasible and supported the physician’s workflow. The total duration of follow-up visits comprising technical device 
interrogation and clinical actions was not affected in the present tertiary center outpatient cohort.
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Background
Cardiac pacemakers, implantable cardioverter defibrilla-
tors (ICDs) and cardiac resynchronization therapy (CRT) 
devices are widely used in clinical electrophysiology [1–
4]. The number of cardiovascular implantable electronic 
devices (CIEDs) is increasing due to aging population and 
an extension of CIED implantation indications [5] resulting 
in a rising number of device interrogations. The logistics 
of monitoring these devices represent a substantial chal-
lenge in cardiovascular patient care [6]. As further increase 
in physician work load cannot be expected in the future, 
increasing numbers of CIEDs require optimal technical 
strategies for device follow-up to facilitate device interroga-
tion, data handling, and electronic documentation [7].
During conventional follow-up visits, device data 
obtained through the programmer are transferred 
manually into paper-based patient records or electronic 
patient management systems and device identifica-
tion documents. To optimize quality and duration of 
CIED follow-up visits, an integrated software package 
 (MediConnect®) has been developed, enabling digital 
processing of device follow-up data. Fully digital transfer 
of interrogation data between the programmer and elec-
tronic patient management systems is expected to result 
in increased efficiency with concurrent improvement 
in reporting quality. Furthermore, the low durability of 
thermo paper used to print CIED records poses limita-
tion of paper-based follow-up with regard to data stor-
age. Using fully digital solutions, parameters obtained 
during device interrogation are imported electronically 
in standardized fashion into the data management sys-
tem. Written reports and device identification cards are 
generated automatically by the software. The normaliza-
tion results in a uniform follow-up process for different 
devices and manufacturers which may improve work-
flow productivity.
CIED follow-up in a tertiary center is characterized by 
high patient numbers, considerable complexity of indi-
vidual cases, and significant comorbidities of outpatients 
presenting for routine interrogation. The aim of this work 
was to evaluate the feasibility of digital CIED data pro-
cessing using  MediConnect® software in a high-volume 
tertiary hospital.
Methods
Study design and patient population
Between November 2013 and November 2015, a total 
of 18,449 patients presented to the electrophysiology 
outpatient clinic at the department of cardiology, Medi-
cal University Hospital Heidelberg (Germany). A sample 
cohort of 391 patients scheduled for routine follow-up 
of cardiac pacemakers, ICDs, or CRT devices were pro-
spectively enrolled. Study patients underwent CIED 
interrogation, followed by either manual or digital trans-
fer  (MediConnect®; Fleischhacker, Schwerte, Germany) 
of device data into the electronic patient management 
system (i.s.h.med®, SAP, Walldorf, Germany) installed 
on Windows (Microsoft, Redmond, WA, USA)—based 
personal computer workstations. The decision between 
manual and digital data processing was left to the phy-
sician’s discretion. Baseline characteristics and proce-
dural data were analyzed. Total duration of the follow-up 
visit was measured from each study subject entering the 
examination room to the receipt of written medi-
cal reports and updated device identification card by the 
respective patient.
CIED device interrogation and manual data transfer
Device interrogation was performed through telemetry 
(Fig. 1). Specific programmers were used to retrieve pro-
grammed parameters and data stored on pacemakers, 
ICDs and CRT devices from the following manufacturers: 
Fig. 1 Comparison of manual and digital CIED interrogation data processing during device follow-up
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Biotronik (Berlin, Germany), Boston Scientific (Marlbor-
ough, MA, USA), LivaNova (London, UK), Medtronic 
(Minneapolis, MN, USA), St. Jude Medical (St. Paul, MN, 
USA), and Vitatron (Maastricht, the Netherlands). Oper-
ating parameters of the devices were modified if required. 
Interrogation data were then transferred manually into a 
Microsoft Word-based file of the i.s.h.med® patient man-
agement system, allowing for electronic documentation 
and generation of a medical report. Furthermore, the 
data were manually entered into a paper-based device 
identification card. Additional tasks were performed at 
the physician’s discretion (e.g., obtaining medical history 
or blood pressure, physical examination, auscultation).
Fully digital data processing (FDDP)
Following device interrogation via appropriate program-
ming devices,  MediConnect® software was employed 
for digital data transfer and for generation of medical 
documents. During the course of the study, five versions 
of the software were used owing to software updates: 
2.6.0.130 (10/2013–3/2014), 2.6.0.138 (3/2014–8/2014), 
2.7.0.10 (8/2014–10/2014), 2.7.0.20 (10/2014–7/2015), 
and 2.7.0.47 (7/2015–11/2015). Patients underwent CIED 
follow-up with the current software version at the time of 
follow-up. The update from 2.6.0.130 to 2.6.0.138 included 
minor modifications. More substantial changes were car-
ried out during the following update to version 2.6.0.10, 
involving optimization of user interface and electrocar-
diogram viewer. Subsequent updates 2.7.0.20 and 2.7.0.47 
were performed to improve stability and performance. 
The list of programming devices and CIEDs recognized 
by the software was updated with each step. Interrogation 
data were stored on a permanently installed USB mass 
storage stick connected to the programming device. The 
follow-up data were then imported automatically via a 
switch box from different programmers employed in par-
allel into  MediConnect® software installed on a personal 
computer, allowing for standardized reading and storage 
of data retrieved from different devices (Fig. 1). Medical 
reports and CIED identification documents were auto-
matically generated by the software package, printed, 
and stored electronically both in  MediConnect® software 
and through import into the electronic patient manage-
ment system (i.s.h.med®). Thus, the integrated approach 
allowed for facilitated handling of interrogation data from 
various manufacturers. Telemedical applications [8] were 
not included in this work.
Statistics
Statistical analyses were performed using Prism 6.0 
(GraphPad, La Jolla, CA, USA) and Origin 8.0 (Origin-
Lab Corporation, Northampton, MA, USA) software, as 
well as “R” software [9] (version 3.3.1) with the packages 
“car” [10] (version 2.1-2) and “xtable” [11] (version 1.8-2). 
Continuous variables are expressed as mean ± SEM. For 
between-group comparisons, the unpaired Student’s t test 
(two-tailed test) was used, assuming that the data were 
approximately normally distributed. Categorical variables 
are described as count and percentage and were analyzed 
using the Chi-square test or Fisher’s exact test (two-tailed 
tests) where appropriate. Furthermore, a linear regres-
sion model for the duration of follow-up visits was applied 
where study group (FDDP vs. conventional follow-up), age, 
gender, concomitant cardiac disease, device manufacturer, 
device type, and physician experience in clinical electro-
physiology were included as predictors. Effect estimates, 
95% confidence intervals (CI), and p values are provided 
in the results section. A p value < 0.05 was considered sta-
tistically significant. Since this was an exploratory analysis, 
no adjustment for multiple testing was applied.
Results
Patient characteristics
A total of 391 patients presenting for ambulatory follow-
up of cardiac pacemakers (n = 173; 44%), ICDs (n = 154; 
39%), or CRT devices (n = 64; 16%) were included (Tables 1 
and 2). The mean age was 70.3 ± 0.7 years, and 249 study 
subjects were male (64%). Manual transfer of device inter-
rogation data was employed in 126 cases (32%), whereas 
fully digital data processing (FDDP) using  MediConnect® 
software was used in 265 patients (68%). The majority of 
patients exhibited concomitant cardiac disease (manual 
data transfer, 80%; FDDP, 74%), with ischemic heart disease 
being the most abundant (Table 1). Sinus rhythm was pre-
sent in 74% (manual data transmission) and 72% of cases 
(FDDP). Twenty-three percent of all study subjects was 
presented in atrial fibrillation. Common CIED indications 
comprised primary and secondary preventions of sud-
den cardiac death, higher degree atrioventricular block, 
and sinus node disease (Table  1). Baseline parameters 
were not significantly different between groups. Pacemak-
ers and ICDs were equally distributed between the groups 
(Table 2). Finally, significant intergroup differences between 
device manufacturers were noted (Table 2). 
A total of 18 physicians follow-up were involved in 
the study. Of these, the majority (n =  11) applied both 
conventional follow-up and FDDP. Five physicians used 
FDDP with  MediConnect® software only, and two phy-
sicians performed CIED follow-up conventionally in 
all patients. In the conventional group, 85.7% (108/126) 
of device interrogations were conducted by investi-
gators routinely using both methods, compared to 
86.8% (230/265) in the FDDP cohort (p =  0.77). Physi-
cian’s experience in clinical electrophysiology differed 
between treatment groups. Physicians who performed 
conventional CIED follow-up displayed 3.2  ±  0.2  years 
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of previous electrophysiological experience, whereas 
in the FDDP cohort, prior experience was lower 
(1.8 ± 0.1 years; p < 0.001).
Efficiency of digital data transfer
The accuracy of data transfer increased with subse-
quent software updates (Table  3). Errors included 
Table 1 Baseline characteristics of study patients
AV atrioventricular node, SA sinoatrial node, SCD sudden cardiac death, SEM standard error of the mean
a Unpaired Student’s t test (two-tailed test)
b Chi-square test (two-tailed test)
c Fisher’s exact test (two-tailed test)
d Includes paroxysmal, persistent, and permanent atrial fibrillation
Manual data processing (n = 126) Fully digital data processing (n = 265) p value
Age (years; mean ± SEM) 72 ± 1.1 69 ± 1.0 0.067a
Male (n; %) 79 (63) 170 (64) 0.78b
Concomitant cardiac disease (n; %) 101 (80) 197 (74) 0.207b
Ischemic heart disease (n; %) 66 (52) 120 (45) 0.19b
Non-ischemic heart disease (n; %) 35 (28) 73 (28) 0.96b
Primary electrical heart disease (n; %) 0 (0) 4 (2) 0.31c
Rhythm at presentation
Sinus rhythm (including complete AV block) (n; %) 93 (74) 192 (72) 0.78b
Atrial  fibrillationd (n; %) 29 (23) 59 (22) 0.87b
Atrial flutter (n; %) 1 (1) 1 (< 1) 0.54c
Sinus arrest/complete SA block (n; %) 3 (2) 13 (5) 0.29c
Device indications
Sinus node disease (n; %) 12 (10) 38 (14) 0.18b
Atrial fibrillation with slow ventricular response rate (n; %) 13 (10) 22 (8) 0.51b
AV block (n; %) 29 (23) 59 (22) 0.87b
Carotid sinus syndrome (n; %) 1 (1) 2 (1) 1.0c
Primary prevention of SCD (n; %) 50 (40) 106 (40) 0.95b
Secondary prevention of SCD (n; %) 21 (17) 38 (14) 0.55b
Table 2 Types and manufacturers of cardiac devices included in the study
Italic values indicate statistically significant associations
CRT cardiac resynchronization therapy device, D defibrillator, ICD implantable cardioverter defibrillator, P pacemaker
a Chi-square test (two-tailed test)
b Fisher’s exact test (two-tailed test)
Manual data processing (n = 126) Fully digital data processing (n = 265) p value
Device type
Single chamber P (n; %) 8 (6) 27 (10) 0.21a
Dual chamber P (n; %) 43 (34) 95 (36) 0.74a
Single chamber ICD (n; %) 46 (37) 77 (29) 0.14a
Dual chamber ICD (n; %) 12 (10) 19 (7) 0.42a
CRT-P (n; %) 2 (2) 0 (0) 0.10b
CRT-D (n; %) 15 (12) 47 (18) 0.14a
Device manufacturer
Biotronik (n; %) 6 (5) 17 (6) 0.52a
Boston Scientific (n; %) 31 (25) 25 (9) < 0.0001a
LivaNova (Ela/Sorin) (n; %) 9 (7) 4 (2) 0.006b
Medtronic (n; %) 56 (44) 155 (58) 0.009a
St. Jude Medical (n; %) 22 (17) 63 (24) 0.16a
Vitatron (n; %) 2 (2) 1 (< 1) 0.24b
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general failure to import interrogation data, incomplete 
import of single values, insufficient transfer of interro-
gation values into documents created by the software, 
and import of incorrect values, respectively. Of note, 
no errors were observed with the final software update 
during the course of the study.  MediConnect® software 
crashes occurred during four of 265 follow-up inves-
tigations (1.5%). In these cases, a reboot of the system 
and a re-login were necessary, which required approxi-
mately 2–3 min. Two additional system reboots (0.75%) 
were actively initiated at the physicians’ discretion 
when document printing failed. Written patient reports 
and device identification cards produced through 
 MediConnect® software were free from errors in 98% 
of cases (Table  3). Incompletely transferred device 
interrogation data were manually completed prior to 
generation of medical documents, if required.
In the present sample cohort, the mean duration of 
follow-up visits using FDDP and automatic document 
production yielded 18.7 ± 0.4 min (n = 265) and was not 
significantly different from patients subjected to manual 
transfer of interrogation data from the programmer into 
electronic documentation system and into paper-based 
device identification cards (18.2  ±  0.8  min; n  =  126; 
p  =  0.49) (Fig.  2). While software updates improved 
the quality of data transfer, mean follow-up duration 
did not change when comparing early software versions 
(16.4 ±  1.0  min; n =  38) with the most recent version 
investigated in the present study (18.4 ± 2.2 min; n = 17; 
p  =  0.37) (Table  4). Multivariate analysis revealed an 
influence of physician’s experience and device type on 
device follow-up duration among potential determi-
nants (i.e., age, gender, concomitant cardiac disease, 
device type and manufacturer, physician’s experience in 
clinical electrophysiology, and conventional vs. FDDP 
follow-up) (Table 5). The duration of ambulatory follow-
up was shorter when performed by more experienced 
physicians.
Technical and clinical events observed during ambulatory 
follow‑up
In addition to device interrogation, the completion 
of reports and CIED identification cards, ambulatory 
CIED follow-up visits included further physician tasks 
contributing to the duration and complexity of device 
follow-up. Obtaining patient’s history, physical exami-
nation, and consultation with other physicians were 
commonly performed without significant differences 
between study groups (Table  6). Furthermore, inter-
rogation of cardiac pacemakers, ICDs, or CRT devices 
Table 3 Accuracy of data transfer using fully digital data processing, stratified by software versions
Software version 2.6.0.130–
2.7.0.10
Software version 2.7.0.20 Software version 2.7.0.47 All software versions
(n = 38) (n = 210) (n = 17) (n = 265)
General failure of data import 
(n; %)
1 (3) 1 (< 1) 0 (0) 2 (1)
Incomplete data import (one or 
more values missing) (n; %)
2 (5) 3 (1) 0 (0) 5 (2)
Incomplete transfer of values 
into documents (one or more 
values missing) (n; %)
2 (5) 3 (1) 0 (0) 5 (2)
Import of incorrect values (n; %) 2 (5) 0 (0) 0 (0) 2 (1)
Fig. 2 Total duration of ambulatory device follow-up. Mean (± SEM) 
visit duration is compared between manual and digital data process-
ing, respectively











Mean (± SEM) 
follow-up dura-
tion (min)
16.4 ± 1.0 19.2 ± 0.4 18.4 ± 2.2
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revealed technical issues such as low battery voltage and 
extended investigation of ICD leads under advisory in 
a minority of patients of both groups (Table 7). Finally, 
additional clinical aspects were addressed during device 
follow-up (Table  8). Ventricular tachycardia or fibril-
lation episodes detected by defibrillator devices repre-
sented the most frequent events and were encountered 
in 16% (manual data transfer group) and 23% of patients 
(FDDP; p  =  0.088). In these cases, further evaluation 
was necessary and options for antiarrhythmic treat-
ment optimization were discussed and initiated when 
appropriate.
Discussion
Feasibility of fully digital data processing in CIED follow‑up
We were able to demonstrate successful implementation 
of FDDP using  MediConnect® software into the clinical 
CIED follow-up workflow at a university hospital. Fea-
sibility of FDDP in routine application is indicated by a 
82% rate of complete and correct data transfer with the 
first three software versions and a 100% rate of correct 
data transfer with the final software version which has 
been used at the end of the study. Software crashes were 
rare (1.5%). Furthermore, medical documents were pro-
duced by the software with very few errors, and provided 
Table 5 Linear regression analysis of total follow-up
Linear regression was applied to adjust for intergroup differences in indicated parameters; * a single p value is provided for parameters “device type” and “device 
manufacturer”
Italic value indicates statistically significant associations
CRT cardiac resynchronization therapy device, D defibrillator, EP electrophysiology, ICD implantable cardioverter defibrillator, P pacemaker
Regression coefficient 95% confidence interval p value
Intercept 20.21 (15.31; 25.11) < 0.001
FDDP use (vs. conventional follow-up) − 0.63 (− 2.22; 0.96) 0.439
Female gender (vs. male) − 0.82 (− 2.27; 0.64) 0.273
Age (per year) 0.03 (− 0.02; 0.08) 0.261
Concomitant cardiac disease 1.41 (− 0.46; 3.27) 0.141
Physician experience in clinical EP (per year) − 1.07 (− 1.39; -0.75) < 0.001
Device type 0.009
Single chamber P (vs. CRT-P/CRT-D) − 2.77 (− 5.83; 0.28) *
Dual chamber P (vs. CRT-P/CRT-D) − 1.84 (− 4.11; 0.43) *
Single chamber ICD (vs. CRT-P/CRT-D) − 3.49 (− 5.67; − 1.32) *
Dual chamber ICD (vs. CRT-P/CRT-D) 0.06 (− 2.94; 3.06) *
Device manufacturer 0.243
Boston Scientific (vs. Medtronic) 1.59 (− 0.62; 3.81) *
Biotronik, LivaNova (Ela/Sorin), Vitatron (vs. Medtronic) 1.20 (− 1.18; 3.59) *
St. Jude Medical (vs. Medtronic) − 0.67 (− 2.48; 1.15) *
Table 6 Tasks performed by the physician during ambulatory patient follow-up
Italic value indicates statistically significant associations
ICD implantable cardioverter defibrillator. No patient was directly admitted to the hospital
a Chi-square test (two-tailed test)
b Fisher’s exact test (two-tailed test)
c In five cases, patients were instructed to keep a copy of the written report (including current device parameters) with their pacemaker identification card issued 
previously
Manual data processing (n = 126) Fully digital data processing (n = 265) p value
Device interrogation (n; %) 126 (100) 265 (100) 1.0b
Written report (n; %) 126 (100) 265 (100) 1.0b
Pacemaker/ICD identification card (n; %) 122 (97)c 265 (100) 0.01b
Brief medical history (n; %) 126 (100) 265 (100) 1.0b
Consultation with other physicians (n; %) 14 (11) 48 (18) 0.08a
Patient transferred to emergency department (n; %) 1 (1) 0 (0) 0.32b
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the added benefit of electronic documentation of both 
patient reports and device identification cards, respec-
tively, eliminating the use of hardcopy archiving. In addi-
tion, removing the need for manual completion of device 
identification cards resulted in increased technical qual-
ity of medical documentation. A low rate of physician 
complaints after an initial  MediConnect® software instal-
lation and adaptation phase indicated satisfaction with 
FDDP performance during the course of the study.
Comparison with manual data transfer
Optimized data transfer between the programming 
device and the electronic documentation system could 
reduce overall duration of follow-up visits. Mean fol-
low-up duration was 19  min in the present study. Con-
trary to expectations, there was no significant difference 
between the follow-up duration using FDDP and manual 
data transmission. Overall times of outpatient visits were 
determined by additional tasks that were carried out by 
Table 7 Device-related technical events identified during patient follow-up
ERI elective replacement indicator, ICD implantable cardioverter defibrillator
a Chi-square test (two-tailed test)
b Fisher’s exact test (two-tailed test)
Manual data processing (n = 126) Fully digital data processing (n = 265) p value
Low battery voltage (n; %) 6 (5) 6 (2) 0.18a
Battery depletion (ERI) (n; %) 2 (2) 4 (2) 1.0b
Significant change in pacing threshold (n; %) 1 (1) 3 (1) 1.0b
Significant change in lead impedance (n; %) 1 (1) 0 (0) 0.32b
Significant change in sensing threshold (n; %) 1 (1) 1 (< 1) 0.54b
Extended tests owing to lead advisory (n; %) 6 (5) 15 (6) 0.71a
Lead dysfunction (n; %) 0 (0) 1 (< 1) 1.0b
Skeletal muscle/nerve stimulation (n; %) 0 (0) 0 (0) 1.0b
Device-related infection (n; %) 0 (0) 0 (0) 1.0b
T-wave oversensing (n; %) 0 (0) 1 (< 1) 1.0b
Pacemaker-mediated tachycardia (n; %) 0 (0) 0 (0) 1.0b
Cross talk (any type) (n; %) 0 (0) 0 (0) 1.0b
Electromagnetic interference (n; %) 0 (0) 1 (< 1) 1.0b
Table 8 Clinical events identified during patient follow-up
ICD implantable cardioverter defibrillator
a Chi-square test (two-tailed test)
b Fisher’s exact test (two-tailed test)
Manual data processing 
(n = 126)
Fully digital data processing 
(n = 265)
p value
Ventricular tachycardia/fibrillation episodes (n; %) 20 (16) 62 (23) 0.088a
Ongoing ventricular tachycardia (n; %) 0 (0) 0 (0) 1.0b
Ongoing supraventricular tachycardia (including AF), requiring 
immediate attention (n; %)
0 (0) 0 (0) 1.0b
Change of medication required owing to cardiac conditions (n; %) 2 (2) 12 (5) 0.24b
Change of medication required owing to non-cardiac conditions 
(n; %)
0 (0) 0 (0) 1.0b
In-depth discussion with patient (n; %) 9 (7) 11 (4) 0.21a
Evaluation of system upgrade from pacemaker to ICD (n; %) 0 (0) 0 (0) 1.0b
Evaluation of system upgrade from pacemaker/ICD to CRT (n; %) 
(n; %)
0 (0) 1 (< 1) 1.0b
Evaluation of system downgrade (n; %) 0 (0) 0 (0) 1.0b
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the physician in addition to device interrogation in the 
setting of a specialized Electrophysiology Outpatient 
Clinic, associated with referral of particularly demanding 
cases. These actions were not affected by the method of 
handling device-related data. Thus, the relative contri-
bution of efficient data transfer to follow-up times may 
have been too low to show significant effects. Increased 
physician’s experience contributed to shorter follow-up 
duration among patients with manual data handling as 
well. Furthermore, there was a tendency towards more 
CRT devices in the FDDP group than in the manual data 
handling group (18% vs. 13%). As CRT follow-up can be 
more time-consuming and requires the investigation of 
more technical parameters compared to pacemakers or 
ICDs, this difference may potentially have outweighed the 
benefits of FDDP. Finally, the duration of  MediConnect® 
software loading processes was noted during the course 
of the study as possible factor contributing to a lack of 
FDDP effects on total follow-up time. Future software 
improvements are expected to allow for exploitation of 
further benefits provided by FDDP use.
Limitations, benefits and future directions
This study has inherent limitations due to the non-ran-
domized patient assignment to treatment groups. A low 
recruiting rate resulted in a relatively low number of 
patients included in the study. It is important to highlight 
that the subpopulation analyzed here represents only a 
small “snapshot” of the “real life” situation at the Electro-
physiology Outpatient Clinic. In addition, the study was 
initiated early after new implementation of fully digital 
data transfer into the clinical workflow. Therefore, ben-
efits of established, long-term FDDP use, expected to 
result in reduced follow-up duration as device records 
will be readily available from the database, could not be 
evaluated. Telemedical applications that may provide sig-
nificant further improvements in CIED patient follow-
up using  MediConnect®-based digital data transfer were 
not included in this study. We recognize a potential bias 
as stratification of the results according to device manu-
facturers or to the respective physicians performing the 
follow-up investigations was not statistically feasible 
in the present sample. However, the open study design 
and resulting uneven distribution of device manufactur-
ers between manual data handling and FDDP groups at 
the physicians’ discretion, respectively, may offer further 
insights into FDDP use. It could be speculated that some 
manufacturers’ devices were more likely used by the 
established, manual process, while others were more fre-
quently subjected to be interrogated using the new FDDP 
workflow algorithm. The hypothesis that FDDP may 
indeed be better suited for some systems, while other 
manufacturers’ devices may be associated with potential 
problems or increased work load, could impact daily clin-
ical routine and needs to be further addressed and evalu-
ated in controlled studies in the future. Potential added 
benefits of digital data transfer using  MediConnect® 
software were not assessed: Electronic storage of device 
interrogation and clinical data in the software pack-
age facilitates the handling of safety information, device 
recalls or scientific investigations among CIED patients. 
While the present study confirms the feasibility of newly 
implemented digital CIED interrogation data transfer in 
a high-volume center, a prospective, randomized multi-
center study is required to further elucidate characteris-
tics of its long-term use in clinical application.
Conclusions
Replacing manual CIED data transfer by automatic, fully 
digital data transfer during routine follow-up is feasible. 
The overall duration of follow-up visits, including device 
interrogation, clinical actions, and case discussions, is 
similar compared with manual data transfer, but may 
decrease with increasing user experience and further 
software improvements. Digital data transfer software 
represents a technical solution to alleviate the growing 
demand in device follow-up caused by increasing num-
bers of CIEDs and offers advantages over manual data 
transfer and paper-based patient records.
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